News
DGX
208.21
-1.56%
-3.31
Quest Diagnostics integrates Haystack MRD ctDNA test within OncoEMR
TipRanks · 19h ago
Quest Diagnostics Now the Largest Clinical Reference Lab to Extend Oncology Test Access Through OncoEMR MPI
PR Newswire · 19h ago
Digi Power X Provides Operations and Financial Update
Barchart · 2d ago
Reminder - Quest Diagnostics (DGX) Goes Ex-Dividend Soon
NASDAQ · 2d ago
Weekly Report: what happened at DGX last week (0629-0703)?
Weekly Report · 2d ago
Quest Diagnostics (DGX) Could Be 4% Undervalued On Haystack MRD Approval
Simply Wall St · 3d ago
The Week That Was, The Week Ahead: Macro and Markets, July 5
TipRanks · 3d ago
How Investors Are Reacting To Quest Diagnostics (DGX) New MRD Test Milestone And Attunio Partnership
Simply Wall St · 5d ago
Quest Diagnostics (DGX) Stock Trades Cheap On Cash Flow But Fair On Earnings
Simply Wall St · 6d ago
Dividend Champion, Contender, And Challenger Highlights: Week Of July 5
Seeking Alpha · 6d ago
Quest Diagnostics's Q2 2026 Earnings: What to Expect
Barchart · 07/01 09:46
Weekly Report: what happened at DGX last week (0622-0626)?
Weekly Report · 06/29 09:55
Did Nationwide Approval of Haystack MRD Liquid Biopsy Just Shift Quest Diagnostics' (DGX) Investment Narrative?
Simply Wall St · 06/25 05:12
Illumina Inc. Stock Rises 6.2%, Outperforms Market
Dow Jones · 06/24 20:34
Quest Diagnostics receives New York approval for Haystack MRD cancer monitoring test
Seeking Alpha · 06/24 13:36
Quest Diagnostics' Haystack MRD Test Wins New York State Approval For Solid Tumor Monitoring
NASDAQ · 06/24 13:10
Quest Diagnostics Receives New York's Department of Health's Clinical Laboratory Evaluation Program Approval For Its Haystack Minimal Residual Disease Liquid Biopsy Test To Trace Residual Or Recurring Disease In Solid Tumor Cancers Patients
Benzinga · 06/24 12:55
Quest Diagnostics’ Haystack MRD test receives New York SDOH approval
TipRanks · 06/24 12:55
15 dividend stocks outpacing Wall Street as the Nasdaq and S&P 500 struggle
Seeking Alpha · 06/23 17:10
Weekly Report: what happened at DGX last week (0615-0619)?
Weekly Report · 06/22 10:01
More
Webull provides a variety of real-time DGX stock news. You can receive the latest news about Quest Diagnostics Inc through multiple platforms. This information may help you make smarter investment decisions.
About DGX
Quest Diagnostics Incorporated is a provider of diagnostic information services. It provides diagnostic insights from the results of its laboratory testing to empower people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and its connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. Its other customers include health plans, employers, emerging retail healthcare providers, government agencies, and others. Its services are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.